Breast Cancer
LA BioMed investigator, Dr. Rowan Chlebowski, co-authors study on menopausal hormone therapy
Published in Women's Health Weekly, March 29th, 2012
2012 MAR 29 -- Rowan T. Chlebowski, M.D., Ph.D., an LA BioMed investigator whose research activities have focused on breast cancer therapy and prevention, and chronic diseases impacting women's health, is co-author of a study that indicates that women who use the estrogen-only form of menopausal hormone therapy appear less likely to develop breast cancer in the longer term, according to new research which was recently published The Lancet Oncology.
A follow-up study of over 7,500 women from the Women's Health Initiative (WHI) trial who took estrogen for about 6 years and then stopped has found that they are over 20 percent less likely to develop breast...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Uterine Prolapse
Data from B. Feiner et al Provide New Insights into Uterine Prolapse - Breast Cancer
Data from Massachusetts General Hospital Provide New Insights into Breast Cancer - Breast Cancer
Data on Breast Cancer Described by Researchers at Lund University - Cervical Cancer
Data on Cervical Cancer Reported by Researchers at CIBERESP - Ovarian Cancer
Data on Ovarian Cancer Published by S. Viswanathan and Colleagues - Women's Health
Data on Women's Health Discussed by Researchers at University of Genoa - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
